Baijin Life Science Holdings Limited (HKG:1466)
0.530
-0.020 (-3.64%)
Mar 10, 2026, 1:19 PM HKT
HKG:1466 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 513 | 488 | 442 | 454 | 39 | 33 | Upgrade
|
| Market Cap Growth | 29.50% | 10.50% | -2.73% | 1063.93% | 17.12% | -48.57% | Upgrade
|
| Enterprise Value | 557 | 529 | 403 | 441 | 44 | 50 | Upgrade
|
| Last Close Price | 0.55 | 0.69 | 0.65 | 0.71 | 0.12 | 0.12 | Upgrade
|
| PE Ratio | 54.90 | - | - | 52.32 | - | - | Upgrade
|
| PS Ratio | 4.28 | 3.60 | 8.23 | 5.22 | 0.62 | 0.77 | Upgrade
|
| PB Ratio | 3.25 | 3.13 | 3.91 | 5.80 | 1.09 | 0.73 | Upgrade
|
| P/TBV Ratio | 4.78 | 4.65 | 10.88 | 5.80 | 1.09 | 0.73 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 36.69 | - | Upgrade
|
| P/OCF Ratio | - | - | - | - | 35.16 | - | Upgrade
|
| EV/Sales Ratio | 4.65 | 3.91 | 7.51 | 5.08 | 0.70 | 1.15 | Upgrade
|
| EV/EBITDA Ratio | 49.10 | 29.90 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 110.73 | 37.69 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | -27.01 | - | - | - | 41.09 | - | Upgrade
|
| Debt / Equity Ratio | 0.54 | 0.64 | 0.45 | 0.04 | 0.89 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 7.53 | 4.83 | - | - | 28.25 | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 29.95 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.17 | 0.33 | 0.11 | -0.50 | 0.21 | 0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.12 | 2.90 | -1.41 | 15.75 | -196.54 | -0.17 | Upgrade
|
| Net Debt / FCF Ratio | -1.33 | -1.56 | -1.90 | 1.81 | 7.21 | -0.43 | Upgrade
|
| Asset Turnover | 0.46 | 0.56 | 0.36 | 0.96 | 0.72 | 0.35 | Upgrade
|
| Inventory Turnover | 1.45 | 1.63 | 0.80 | 2.31 | 2.12 | 1.76 | Upgrade
|
| Quick Ratio | 2.68 | 2.93 | 1.68 | 2.34 | 1.12 | 1.41 | Upgrade
|
| Current Ratio | 4.21 | 4.57 | 2.96 | 4.69 | 1.75 | 1.98 | Upgrade
|
| Return on Equity (ROE) | 3.26% | -0.07% | -8.94% | 15.20% | -37.80% | -79.02% | Upgrade
|
| Return on Assets (ROA) | 1.21% | 3.60% | -4.04% | -1.84% | -0.16% | -21.10% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.72% | 8.45% | -11.64% | -6.46% | -0.47% | -60.37% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.20% | 5.80% | -6.10% | -3.40% | -0.60% | -91.40% | Upgrade
|
| Earnings Yield | 1.58% | -0.07% | -1.69% | 1.91% | -39.65% | -155.52% | Upgrade
|
| FCF Yield | -4.02% | -6.76% | -1.50% | -4.75% | 2.73% | -48.67% | Upgrade
|
| Buyback Yield / Dilution | -21.34% | -7.58% | -6.89% | -70.17% | -58.07% | -23.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.